Rising life expectancy and the growing global population make access to high-quality medical care increasingly important. Fresenius is committed to providing access to healthcare and medicine to as many people as possible worldwide.
Reporting in this chapter encompasses two categories that we deem essential:
The Fresenius Group’s revenue encompasses the market segments healthcare products and healthcare and services. Healthcare and services, i. e., the care of patients in our own healthcare facilities, accounts for the majority of revenue with approximately 71%. Further information on our markets can be found in the Healthcare industry section of the Group Management Report 2022.
Revenue by market segment 2022
Download(XLS, 35 KB)Fresenius Medical Care |
Fresenius Kabi |
Fresenius Helios |
Fresenius Vamed |
|
---|---|---|---|---|
Share of Group revenue, in % | 47% | 19% | 29% | 5% |
Thereof healthcare and services | 79% | 0% | 100% | 100% |
Thereof healthcare products | 21% | 100% | 0% | 0% |
Group revenue split 2022